Tackling mPDAC: chemotherapy strategies that matter

May 19, 2025 00:21:51
Tackling mPDAC: chemotherapy strategies that matter
COR2ED - Oncology Medical Conversation
Tackling mPDAC: chemotherapy strategies that matter

May 19 2025 | 00:21:51

/

Show Notes

Metastatic pancreatic ductal adenocarcinoma (mPDAC) is notoriously aggressive with a poor prognosis. It is often diagnosed late, and by this time, surgery is usually not an option. Median overall survival without treatment is just a few months but with systemic chemotherapy this can be improved.   

This video includes the highlights from a video podcast where medical oncologists Prof Shubham Pant and Prof Efrat Dotan discuss how to choose and optimise the different chemotherapeutic options at first and second line. 

Key clinical takeaways: 

You can also watch a video of the experts in conversation and download the accompanying transcript on our website: https://cor2ed.com/gi-connect/programmes/tackling-mpdac/?media=0 

Or watch on YouTube: https://youtu.be/8YxRnjOYUv4 

Follow us on social media: 

LinkedIn: https://www.linkedin.com/company/giconnect 

X: https://x.com/giconnectInfo 

This content is intended for healthcare professionals only. 

The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution.  This podcast is supported by an Independent Education Grant from Ipsen USA. 

This podcast is developed by cor2ed.com 

Published May 2025 

Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released.

Other Episodes

Episode

January 20, 2025 00:27:12
Episode Cover

Intermediate HCC – The evolving role of IO

Intermediate HCC – The evolving role of IO  In this final episode of the four-part series on hepatocellular carcinoma (HCC), hosted by the Oncology...

Listen

Episode

December 06, 2023 00:23:31
Episode Cover

Prostate cancer: Shared decision-making in nmCRPC

Brenda Martone, a nurse practitioner at Northwestern Medicine in Chicago Illinois and Dr Alicia Morgans, Genitourinary Medical Oncologist at the Dana-Farber Cancer Institute in...

Listen

Episode

March 28, 2024 00:23:40
Episode Cover

mCRC: Optimising patient outcomes with late-line treatment

What treatment options are available for patients with metastatic colorectal cancer who have already progressed through multiple lines of therapy?  How can we select...

Listen